IL6R and intrahepatic cholangiocarcinoma: They cause this effect through high expression of microvasculature signature genes and IL-6, along with their intimate interaction with ICC cells via the IL-6/IL-6R pathway, which in turn modulate tumor epigenetic alterations (Zhang et al., 2020).